XML 39 R29.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

REVENUE (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Revenue from Contract with Customer [Abstract] |
Schedule of Total Revenue by Type and by U.S versus Rest of World | The following table presents detail regarding the composition of the Company’s total revenue by product type and by geographical region, either U.S. or rest of world (“RoW”):
| Three months ended March 31,
| 2024 |  |  | 2023
(in millions) | U.S. |  | RoW |  | Total |  |  | U.S. |  | RoW |  | Total
Testing revenues: |  |  |  |  |  |  |  |  |  |  |  |
Hereditary Cancer | $ | 76.3 |  |  | $ | 11.8 |  |  | $ | 88.1 |  |  |  | $ | 64.0 |  |  | $ | 11.7 |  |  | $ | 75.7 |
Tumor Profiling | 23.9 |  |  | 7.0 |  |  | 30.9 |  |  |  | 28.8 |  |  | 8.5 |  |  | 37.3 |
Prenatal | 44.1 |  |  | 0.2 |  |  | 44.3 |  |  |  | 36.0 |  |  | 0.2 |  |  | 36.2 |
Pharmacogenomics | 38.9 |  |  | — |  |  | 38.9 |  |  |  | 32.0 |  |  | — |  |  | 32.0 |
Total revenue | $ | 183.2 |  |  | $ | 19.0 |  |  | $ | 202.2 |  |  |  | $ | 160.8 |  |  | $ | 20.4 |  |  | $ | 181.2 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration